Skip to content

A Study to Evaluate the Effects of a Fiber Supplement on Gut Health

A Study to Evaluate the Effects of a Fiber Supplement on Gut Health

Status
Completed
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07755735
Enrollment
50
Registered
2026-08-10
Start date
2025-08-26
Completion date
2026-01-12
Last updated
2026-08-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bloating, Gastrointestinal Symptoms, Gut Health, Irregular Bowel Movements

Brief summary

This is a randomized, triple-blind, placebo-controlled clinical trial evaluating the effects of BelliWelli Daily Fiber + Probiotics supplement on gut health over 12 weeks. One hundred participants with self-reported gut health issues will be randomized to receive either the active fiber supplement or a matched placebo product, taken twice daily. Participants will complete questionnaires and provide waist and body composition measurements at Baseline, Week 4, Week 8, and Week 12. The primary outcomes include changes in overall gut health scores, waist circumference, and body composition. Secondary outcomes include participant-perceived effects on bloating, regularity, hydration, energy, and hair, skin, and nail support.

Interventions

DIETARY_SUPPLEMENTActive Supplement

Participants receive BelliWelli Daily Fiber + Probiotics supplement containing Collagen Peptides (Bovine) (2 g), Niacin as Niacinamide (7.5 mg), Magnesium as Magnesium Citrate (75 mg), Sodium as Sea Salt (75 mg), Potassium as Potassium Chloride (100 mg), Bacillus coagulans MTCC 5856 (10 mg / 1 billion CFU), and Acacia Fiber (4.0 g), consumed twice per day for 12 weeks.

DIETARY_SUPPLEMENTPlacebo Comparator

Participants receive a taste- and appearance-matched placebo product containing Maltodextrin, Organic Cane Sugar, Natural Flavors, Citric Acid, Malic Acid, Silicon Dioxide, Stevia Leaf Extract, Beet Juice (color), and Fruit and Vegetable Juice (color), consumed twice per day for 12 weeks.

Sponsors

Belli Welli Inc.
Lead SponsorINDUSTRY
Citruslabs
CollaboratorINDUSTRY

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
TRIPLE (Subject, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Be male or female * Be aged 18 or older * Experiencing issues regarding all of the following over the past 4 weeks: bloating, irregular bowel movements, and self-perceived poor gut health * Generally healthy - does not live with any uncontrolled chronic disease * Willing to discontinue any other supplements or herbal remedies that target gut or digestive health * Not planning on introducing any products or any new forms of prescription medication or supplements that target gut health for the study duration * Willing to maintain current diet, sleep pattern, and activity levels for the duration * Resides in the United States * Not currently partaking in another research study and will not be partaking in any other research study for the next 12 weeks and at any point during this study's duration

Exclusion criteria

* Anyone with pre-existing chronic conditions that would prevent participants from adhering to the protocol, including oncological and psychiatric disorders * Anyone with a known history of severe digestive disorders like acid reflux, Irritable Bowel Syndrome (IBS), Irritable Bowel Disease (IBD), Crohn's disease, or gastrointestinal tract surgeries * Anyone with any allergies or sensitivities to any of the study product ingredients * Any women who are pregnant, breastfeeding, or trying to conceive (or who will be at any point during the study period) * Anyone who is vegan and/or does not consume animal products for any reasons * Anyone unwilling to follow the study protocol * Anyone with a history of substance abuse

Design outcomes

Primary

MeasureTime frameDescription
Change in Overall Gut Health ScoreBaseline, Week 4, Week 8, and Week 12Mean change in GSRS (Gastrointestinal Symptoms Rating Scale) total score from baseline as assessed via self-reported questionnaire
Change in Bowel Movement QualityBaseline, Week 4, Week 8, and Week 12Mean change in stool form and consistency as assessed via the Bristol Stool Scale self-reported questionnaire
Change in Self-Reported HydrationBaseline, Week 4, Week 8, and Week 12Mean change in self-reported hydration as assessed via self-reported questionnaire
Change in Self-Reported BloatingBaseline, Week 4, Week 8, and Week 12Mean change in self-reported bloating as assessed via self-reported questionnaire
Change in Waist CircumferenceBaseline, Week 4, Week 8, and Week 12Mean change in waist circumference from baseline as assessed via tape measure waist measurement
Change in Body WeightBaseline, Week 4, Week 8, and Week 12Mean change in body weight from baseline as assessed via Withings Smart Scale
Change in Muscle MassBaseline, Week 4, Week 8, and Week 12Mean change in muscle mass from baseline as assessed via Withings Smart Scale
Change in Fat MassBaseline, Week 4, Week 8, and Week 12Mean change in fat mass from baseline as assessed via Withings Smart Scale
Change in Visceral Fat MassBaseline, Week 4, Week 8, and Week 12Mean change in visceral fat mass from baseline as assessed via Withings Smart Scale

Secondary

MeasureTime frameDescription
Change in Self-Reported RegularityBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived bowel movement regularity as assessed via self-reported questionnaire
Change in Self-Reported HydrationBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived hydration as assessed via self-reported questionnaire
Change in Self-Reported Stool FeelingBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived stool feeling as assessed via self-reported questionnaire
Change in Self-Reported Energy LevelsBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived energy levels as assessed via self-reported questionnaire
Change in Self-Reported HairBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived hair, skin, and nail support as assessed via self-reported questionnaire
Change in Self-Reported SkinBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived hair, skin, and nail support as assessed via self-reported questionnaire
Change in Self-Reported Nail SupportBaseline, Week 4, Week 8, and Week 12Mean change in participant-perceived hair, skin, and nail support as assessed via self-reported questionnaire

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 11, 2026